SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2

As of January 2022, at least 60 million individuals are estimated to develop post-acute sequelae of SARS-CoV-2 (PASC) after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While elevated levels of SARS-CoV-2-specific T cells have been observed in non-specific PASC, littl...

Descripción completa

Detalles Bibliográficos
Autores principales: Littlefield, Katherine M., Watson, Renée O., Schneider, Jennifer M., Neff, Charles P., Yamada, Eiko, Zhang, Min, Campbell, Thomas B., Falta, Michael T., Jolley, Sarah E., Fontenot, Andrew P., Palmer, Brent E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176759/
https://www.ncbi.nlm.nih.gov/pubmed/35617421
http://dx.doi.org/10.1371/journal.ppat.1010359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176759/
https://www.ncbi.nlm.nih.gov/pubmed/35617421
http://dx.doi.org/10.1371/journal.ppat.1010359

Ejemplares similares